218 related articles for article (PubMed ID: 12553744)
1. L-arginine in cardiovascular disease: dream or reality?
Tousoulis D; Antoniades C; Tentolouris C; Goumas G; Stefanadis C; Toutouzas P
Vasc Med; 2002 Aug; 7(3):203-11. PubMed ID: 12553744
[TBL] [Abstract][Full Text] [Related]
2. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
Böger RH; Ron ES
Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
Tousoulis D; Böger RH; Antoniades C; Siasos G; Stefanadi E; Stefanadis C
Nat Clin Pract Cardiovasc Med; 2007 May; 4(5):274-83. PubMed ID: 17457351
[TBL] [Abstract][Full Text] [Related]
5. L-arginine, tetrahydrobiopterin, nitric oxide and diabetes.
Hoang HH; Padgham SV; Meininger CJ
Curr Opin Clin Nutr Metab Care; 2013 Jan; 16(1):76-82. PubMed ID: 23164986
[TBL] [Abstract][Full Text] [Related]
6. L-Arginine: rediscovery in progress.
Tenenbaum A; Fisman EZ; Motro M
Cardiology; 1998 Dec; 90(3):153-9. PubMed ID: 9892762
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiological and clinical aspects of using L-arginine in cardiology and angiology].
Valeev VV; Trashkov AP; Kovalenko AL; Vasil'ev AG
Angiol Sosud Khir; 2016; 22(3):9-15. PubMed ID: 27626244
[TBL] [Abstract][Full Text] [Related]
8. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
[TBL] [Abstract][Full Text] [Related]
9. Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters.
Closs EI; Scheld JS; Sharafi M; Förstermann U
Mol Pharmacol; 2000 Jan; 57(1):68-74. PubMed ID: 10617680
[TBL] [Abstract][Full Text] [Related]
10. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
Böger RH
Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases.
Goumas G; Tentolouris C; Tousoulis D; Stefanadis C; Toutouzas P
Atherosclerosis; 2001 Feb; 154(2):255-67. PubMed ID: 11166757
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.
Toutouzas K; Riga M; Stefanadi E; Stefanadis C
Horm Metab Res; 2008 Sep; 40(9):655-9. PubMed ID: 18792879
[TBL] [Abstract][Full Text] [Related]
13. Role of adenosine transport in gestational diabetes-induced L-arginine transport and nitric oxide synthesis in human umbilical vein endothelium.
Vásquez G; Sanhueza F; Vásquez R; González M; San Martín R; Casanello P; Sobrevia L
J Physiol; 2004 Oct; 560(Pt 1):111-22. PubMed ID: 15272035
[TBL] [Abstract][Full Text] [Related]
14. Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders.
Gawrys J; Gajecki D; Szahidewicz-Krupska E; Doroszko A
Oxid Med Cell Longev; 2020; 2020():1015908. PubMed ID: 32215167
[TBL] [Abstract][Full Text] [Related]
15. Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects.
Lorin J; Zeller M; Guilland JC; Cottin Y; Vergely C; Rochette L
Mol Nutr Food Res; 2014 Jan; 58(1):101-16. PubMed ID: 23740826
[TBL] [Abstract][Full Text] [Related]
16. The pharmacodynamics of L-arginine.
Böger RH
Altern Ther Health Med; 2014; 20(3):48-54. PubMed ID: 24755570
[TBL] [Abstract][Full Text] [Related]
17. [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
Bode-Böger SM
Dtsch Med Wochenschr; 2005 Mar; 130(11):593-8. PubMed ID: 15761791
[TBL] [Abstract][Full Text] [Related]
18. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
Pernow J; Jung C
Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041
[TBL] [Abstract][Full Text] [Related]
19. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress.
Zhang WZ; Venardos K; Chin-Dusting J; Kaye DM
Hypertension; 2006 Aug; 48(2):278-85. PubMed ID: 16801489
[TBL] [Abstract][Full Text] [Related]
20. L-Arginine and its metabolites in kidney and cardiovascular disease.
Popolo A; Adesso S; Pinto A; Autore G; Marzocco S
Amino Acids; 2014 Oct; 46(10):2271-86. PubMed ID: 25161088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
